Cover of ATAGI advice on the use of Bexsero® vaccine


ATAGI advice on the use of Bexsero® vaccine

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
1 March 2014
Last updated: 
1 August 2018
Publication type: 
Intended audience: 
Health sector

This document contains Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers about the use of Bexsero®, a recombinant multicomponent meningococcal B vaccine (4CMenB).

It includes information about transport, storage and handling, dosage and administration, recommendations, contraindications, adverse events and references to more detailed information.